OliX Financial Statements From 2010 to 2024

226950 Stock   21,000  100.00  0.48%   
OliX PharmaceuticalsI financial statements provide useful quarterly and yearly information to potential OliX PharmaceuticalsInc investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on OliX PharmaceuticalsI financial statements helps investors assess OliX PharmaceuticalsI's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting OliX PharmaceuticalsI's valuation are summarized below:
OliX PharmaceuticalsInc does not presently have any trending fundamental ratios for analysis.
Check OliX PharmaceuticalsI financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OliX PharmaceuticalsI's main balance sheet or income statement drivers, such as , as well as many indicators such as . OliX financial statements analysis is a perfect complement when working with OliX PharmaceuticalsI Valuation or Volatility modules.
  
This module can also supplement various OliX PharmaceuticalsI Technical models . Check out the analysis of OliX PharmaceuticalsI Correlation against competitors.

OliX PharmaceuticalsInc Company Shares Outstanding Analysis

OliX PharmaceuticalsI's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current OliX PharmaceuticalsI Shares Outstanding

    
  6.51 M  
Most of OliX PharmaceuticalsI's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, OliX PharmaceuticalsInc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Based on the latest financial disclosure, OliX PharmaceuticalsInc has 6.51 M of shares currently outstending. This is 96.4% lower than that of the Healthcare sector and 93.91% lower than that of the Biotechnology industry. The shares outstanding for all Republic of Korea stocks is 98.86% higher than that of the company.

OliX PharmaceuticalsInc Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining OliX PharmaceuticalsI's current stock value. Our valuation model uses many indicators to compare OliX PharmaceuticalsI value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across OliX PharmaceuticalsI competition to find correlations between indicators driving OliX PharmaceuticalsI's intrinsic value. More Info.
OliX PharmaceuticalsInc is rated fourth in return on equity category among its peers. It is rated second in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value OliX PharmaceuticalsI by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for OliX PharmaceuticalsI's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About OliX PharmaceuticalsI Financial Statements

OliX PharmaceuticalsI stakeholders use historical fundamental indicators, such as OliX PharmaceuticalsI's revenue or net income, to determine how well the company is positioned to perform in the future. Although OliX PharmaceuticalsI investors may analyze each financial statement separately, they are all interrelated. For example, changes in OliX PharmaceuticalsI's assets and liabilities are reflected in the revenues and expenses on OliX PharmaceuticalsI's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in OliX PharmaceuticalsInc. Please read more on our technical analysis and fundamental analysis pages.

Pair Trading with OliX PharmaceuticalsI

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OliX PharmaceuticalsI position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OliX PharmaceuticalsI will appreciate offsetting losses from the drop in the long position's value.

Moving together with OliX Stock

  0.64326030 Sk BiopharmaceuticalsPairCorr
  0.69298380 ABL BioPairCorr

Moving against OliX Stock

  0.62029780 Samsung CardPairCorr
  0.44078020 EBEST Investment SecPairCorr
  0.32235980 MedPactoPairCorr
  0.31014680 Hansol ChemicaPairCorr
The ability to find closely correlated positions to OliX PharmaceuticalsI could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OliX PharmaceuticalsI when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OliX PharmaceuticalsI - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OliX PharmaceuticalsInc to buy it.
The correlation of OliX PharmaceuticalsI is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OliX PharmaceuticalsI moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OliX PharmaceuticalsInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OliX PharmaceuticalsI can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in OliX Stock

OliX PharmaceuticalsI financial ratios help investors to determine whether OliX Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in OliX with respect to the benefits of owning OliX PharmaceuticalsI security.